Giovanni B Nardelli
Overview
Explore the profile of Giovanni B Nardelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trento M, Munari G, Carraro V, Lanza C, Salmaso R, Pizzi S, et al.
Int J Gynecol Pathol
. 2019 Nov;
39(4):305-312.
PMID: 31688243
Carcinosarcomas are rare, highly aggressive neoplasms composed of a combination of carcinomatous and sarcomatous elements. These tumors represent a paradigmatic field for the study of intratumor heterogeneity. A series of...
2.
Ruffatti A, Favaro M, Hoxha A, Zambon A, Marson P, Ross T, et al.
J Reprod Immunol
. 2016 Apr;
115:14-9.
PMID: 27088752
Pregnant women with triple antibody positive antiphospholipid syndrome (APS) who have had thrombosis or a history of early, severe pregnancy complications are generally considered at high risk of pregnancy loss....
3.
Gizzo S, Andrisani A, Noventa M, Quaranta M, Esposito F, Armanini D, et al.
Reprod Biol Endocrinol
. 2015 Apr;
13:28.
PMID: 25884482
Background: Aim of the study was to investigate whether menstrual cycle length may be considered as a surrogate measure of reproductive health, improving the accuracy of biochemical/sonographical ovarian reserve test...
4.
Gizzo S, Noventa M, Saccardi C, Litta P, DAntona D, Nardelli G
Eur J Cancer Prev
. 2014 Sep;
23(6):514-5.
PMID: 25254310
No abstract available.
5.
Noventa M, Andrisani A, Gizzo S, Nardelli G, Ambrosini G
Reprod Biol Endocrinol
. 2014 Jun;
12:48.
PMID: 24885125
Background: Current evidence about in-vivo effects of HPV cannot definitively clarify the possible negative role of this worldwide common infection in early embryo development. However in-vitro evidence, seems to underline...
6.
Patrelli T, Silini E, Gizzo S, Berretta R, Franchi L, Thai E, et al.
BMC Cancer
. 2011 May;
11:171.
PMID: 21575150
Background: Of all female genital tract tumors, 1-3% are stromal malignancies. In 8-10% of cases, these are represented by Müllerian adenosarcoma an extremely rare tumor characterized by a stromal component...
7.
Berretta R, Rolla M, Patrelli T, Piantelli G, Merisio C, Melpignano M, et al.
Aust N Z J Obstet Gynaecol
. 2010 Aug;
50(4):391-6.
PMID: 20716270
Background: Median laparotomy is the most common approach to the abdominopelvic cavity in patients with gynaecological tumours. Aims: The primary endpoint of the study was to evaluate the onset of...
8.
Pezzuto A, Serboli G, Ceccaroni M, Ferrari B, Nardelli G, Minelli L
Gynecol Endocrinol
. 2010 Jun;
26(12):894-6.
PMID: 20515257
We report two cases of two women underwent laparoscopic hysterectomy and myomectomy. During surgery, three myomas were identified as completely detached from the uterus, and attached to the bowel. Patients's...
9.
Cosmi E, Saccardi C, Litta P, Nardelli G, Dessole S
Int J Gynaecol Obstet
. 2010 May;
110(3):262-4.
PMID: 20488441
Objective: To compare the accuracy of transvaginal ultrasound and sonohysterography (SHG) in diagnosing residual trophoblastic tissue in postpartum women and to assess the adverse effects and complications of the SHG...
10.
Berretta R, Patrelli T, Fadda G, Merisio C, Gramellini D, Nardelli G
Int J Gynecol Cancer
. 2009 Jun;
19(4):808-10.
PMID: 19509593
Uterine tumors resembling ovarian sex cord tumors (UTROSCT) are distinguished into two separate groups: endometrial stromal tumors with sex cord-like elements (Group I), which have an unfavorable prognosis; and UTROSCT...